These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Orofacial fungal infections. Nine pathogens that may invade during chemotherapy. Dreizen S; Keating MJ; Beran M Postgrad Med; 1992 Apr; 91(5):349-50, 353-4, 357-60 passim. PubMed ID: 1561171 [TBL] [Abstract][Full Text] [Related]
46. Management of mycoses in surgical patients -- review of the literature. Holzheimer RG; Dralle H Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912 [TBL] [Abstract][Full Text] [Related]
47. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Duong TA Clin Infect Dis; 1996 Jul; 23(1):125-30. PubMed ID: 8816141 [TBL] [Abstract][Full Text] [Related]
49. Mycoses associated with AIDS in the Third World. Marques SA; Robles AM; Tortorano AM; Tuculet MA; Negroni R; Mendes RP Med Mycol; 2000; 38 Suppl 1():269-79. PubMed ID: 11204155 [TBL] [Abstract][Full Text] [Related]
50. Penicilliosis marneffei and pythiosis: emerging tropical diseases. Kaufman L Mycopathologia; 1998; 143(1):3-7. PubMed ID: 10205881 [TBL] [Abstract][Full Text] [Related]
51. Fungal infection of cystic fibrosis patients - single center experience. Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177 [TBL] [Abstract][Full Text] [Related]
52. Epidemiology and identification of potential fungal pathogens causing invasive fungal infections in a tertiary care hospital in northeast Thailand. Faksri K; Kaewkes W; Chaicumpar K; Chaimanee P; Wongwajana S Med Mycol; 2014 Nov; 52(8):810-8. PubMed ID: 25231771 [TBL] [Abstract][Full Text] [Related]
53. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300 [TBL] [Abstract][Full Text] [Related]
54. Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How? Alanio A; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S Clin Microbiol Rev; 2017 Jul; 30(3):671-707. PubMed ID: 28490578 [TBL] [Abstract][Full Text] [Related]
55. Current clinical issues on mycoses in neutropenic patients. Meunier F Int J Antimicrob Agents; 1996 Feb; 6(3):135-40. PubMed ID: 18611699 [TBL] [Abstract][Full Text] [Related]
56. [Quantitative real-time polymerase chain reaction for the diagnosis of invasive fungal disease]. Lu QY; Yu J; Gao LJ; Zheng G; Li RY Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(12):822-6. PubMed ID: 22781455 [TBL] [Abstract][Full Text] [Related]
57. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. Pagano L; Akova M; Dimopoulos G; Herbrecht R; Drgona L; Blijlevens N J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i5-14. PubMed ID: 21177404 [TBL] [Abstract][Full Text] [Related]
58. Role of opportunistic fungi in ocular infections in Nigeria. Gugnani HC; Gupta S; Talwar RS Mycopathologia; 1978 Dec; 65(1-3):155-66. PubMed ID: 745623 [TBL] [Abstract][Full Text] [Related]
59. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Espinel-Ingroff A Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349 [TBL] [Abstract][Full Text] [Related]
60. Detection of a wide range of medically important fungi by the polymerase chain reaction. Makimura K; Murayama SY; Yamaguchi H J Med Microbiol; 1994 May; 40(5):358-64. PubMed ID: 8176723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]